| The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements AM Hoffmann-Vold, TM Maher, EE Philpot, A Ashrafzadeh, R Barake, ... The Lancet Rheumatology 2 (2), e71-e83, 2020 | 223 | 2020 |
| BSR and BHPR guideline for the treatment of systemic sclerosis CP Denton, M Hughes, N Gak, J Vila, MH Buch, K Chakravarty, ... Rheumatology 55 (10), 1906-1910, 2016 | 201 | 2016 |
| Digital ulcers in systemic sclerosis M Hughes, AL Herrick Rheumatology 56 (1), 14-25, 2017 | 174 | 2017 |
| Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis M Hughes, VH Ong, ME Anderson, F Hall, P Moinzadeh, B Griffiths, ... Rheumatology 54 (11), 2015-2024, 2015 | 147 | 2015 |
| Raynaud phenomenon and digital ulcers in systemic sclerosis M Hughes, Y Allanore, L Chung, JD Pauling, CP Denton, ... Nature Reviews Rheumatology 16 (4), 208-221, 2020 | 121 | 2020 |
| Systemic sclerosis M Hughes, Y Allanore, C Denton, M Matucci-Cerinic EMJ Rheumatol 7 (1), 100-109, 2020 | 101 | 2020 |
| Systemic sclerosis M Hughes, AL Herrick British journal of hospital medicine 80 (9), 530-536, 2019 | 101 | 2019 |
| Calcium channel blockers for primary Raynaud's phenomenon H Ennis, M Hughes, ME Anderson, J Wilkinson, AL Herrick Cochrane Database of Systematic Reviews, 2016 | 100 | 2016 |
| Raynaud's phenomenon M Hughes, AL Herrick Best Practice & Research Clinical Rheumatology 30 (1), 112-132, 2016 | 98 | 2016 |
| Raynaud’s phenomenon—an update on diagnosis, classification and management JD Pauling, M Hughes, JE Pope Clinical rheumatology 38, 3317-3330, 2019 | 92 | 2019 |
| Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low … M Hughes, JB Lilleker, AL Herrick, H Chinoy Annals of the rheumatic diseases 74 (5), 795-798, 2015 | 79 | 2015 |
| Gender-related differences in systemic sclerosis M Hughes, JD Pauling, L Armstrong-James, CP Denton, P Galdas, ... Autoimmunity reviews 19 (4), 102494, 2020 | 78 | 2020 |
| A study comparing videocapillaroscopy and dermoscopy in the assessment of nailfold capillaries in patients with systemic sclerosis–spectrum disorders M Hughes, T Moore, N O’Leary, A Tracey, H Ennis, G Dinsdale, A Murray, ... Rheumatology 54 (8), 1435-1442, 2015 | 71 | 2015 |
| The role of chest CT in deciphering interstitial lung involvement: Systemic sclerosis versus COVID-19 M Orlandi, N Landini, G Sambataro, C Nardi, L Tofani, C Bruni, ... Rheumatology 61 (4), 1600-1609, 2022 | 58 | 2022 |
| Prediction and impact of attacks of Raynaud’s phenomenon, as judged by patient perception M Hughes, A Snapir, J Wilkinson, D Snapir, FM Wigley, AL Herrick Rheumatology 54 (8), 1443-1447, 2015 | 57 | 2015 |
| Successful use of tocilizumab in a patient with psoriatic arthritis M Hughes, H Chinoy Rheumatology 52 (9), 1728-1729, 2013 | 44 | 2013 |
| Exploring the patient experience of digital ulcers in systemic sclerosis M Hughes, JD Pauling Seminars in arthritis and rheumatism 48 (5), 888-894, 2019 | 41 | 2019 |
| Reduced perfusion in systemic sclerosis digital ulcers (both fingertip and extensor) can be increased by topical application of glyceryl trinitrate M Hughes, T Moore, J Manning, J Wilkinson, G Dinsdale, C Roberts, ... Microvascular Research 111, 32-36, 2017 | 39 | 2017 |
| Patient-reported outcome instruments for assessing Raynaud’s phenomenon in systemic sclerosis: a SCTC vascular working group report JD Pauling, TM Frech, M Hughes, JK Gordon, RT Domsic, ME Anderson, ... Journal of scleroderma and related disorders 3 (3), 249-252, 2018 | 38 | 2018 |
| Musculoskeletal hand involvement in systemic sclerosis RD Sandler, M Matucci-Cerinic, M Hughes Seminars in arthritis and rheumatism 50 (2), 329-334, 2020 | 37 | 2020 |
